<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
The aim of review. To demonstrate value of H. pylori eradication therapy in patients for prophylaxis and treatment of nonsteroid antiinflammatory drugs (NSAID)- induced gastropathies.Key points. NSAID and H. pylori act as independent risk factors of ulcer development. Eradication therapy is the majo...
Saved in:
| Main Authors: | V. T. Ivashkin, T. L. Lapina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2012-11-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1336 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment and prophylaxis of NSAID-induced gastropathies in a therapeutist’s practice
by: T. L. Lapina
Published: (2009-08-01) -
Unraveling a case of pantoprazole-induced-anaphylaxis requiring tracheostomy: A case report
by: Dawood Tahir, et al.
Published: (2025-02-01) -
The choice of proton pump inhibitor from the standpoint of efficacy and safety in a particular patient
by: E. A. Lyalukova, et al.
Published: (2021-06-01) -
REBAMIPIDE: EFFECTIVE DRUG PREVENTION OF NSAID ENTEROPATHY IS POSSIBLE
by: E. V. Moroz, et al.
Published: (2016-12-01) -
ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ
by: Л. Б. Лазебник, et al.
Published: (2013-06-01)